Postmenopausal exogenous hormone therapy and Melanoma risk in women: A systematic review and time-response meta-analysis

Pharmacol Res. 2022 Feb:176:106054. doi: 10.1016/j.phrs.2021.106054. Epub 2022 Jan 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Estrogen Replacement Therapy
  • Female
  • Hormones
  • Humans
  • Melanoma*
  • Postmenopause*
  • Syndrome

Substances

  • Hormones